The Genetics Podcast
EP 125: The future of UK Clinical Trial Policy: Innovation, integration, and game-changing legislation with Lord James O’Shaughnessy
Listen on
Episode notes
0:00 Introduction
1:25 How Lord O’Shaughnessy became involved in scientific policy making and his path to writing the UK Commercial Clinical Trials Review.
04:05 How Lord O’Shaughnessy pivoted from education to a focus on life sciences
06:38 The biggest challenges Lord O’Shaughnessy faced during his time as Parliamentary Under Secretary for Health (2016-2018)
08:00 Navigating the health and care system through Brexit and the introduction of the General Data Protection Regulation (GDPR)
11:27 How the need for the UK Clinical Trials Review was identified and what challenges and issues brought the project to the fore
13:46 What the report found to explain the decline of clinical trials in the UK?
16:09 Bureaucratic challenges reducing the speed of approval and how best to balance frontline healthcare and research innovation
19:10 How best the National Health Service can support and resource research
21:50 The structural and cultural elements needed to integrate clinical research into the UK healthcare system
23:20 Accessibility of data for research purposes and the key legal and policy frameworks required to support it
26:24 How best to enable successful and safe access to frontline health data for the purposes of research
29:25 Public health emergency legislation as a model for data sharing that could power research into poorly understood conditions with high unmet needs
30:15 Building trust and transparency with the general public around using health data to support research
32:00 Key areas where the UK is excelling in research
34:28 How to ensure that research is fundamental to the healthcare system
36:01 Budgets to invest in innovation
38:35 The challenges of moving to preventative healthcare solutions
40:00 The long-term view of early-stage R&D vs. immediate frontline healthcare
41:44 Key observations on current data and healthcare policies
44:35 Closing remarks
Please consider rating and reviewing us on your chosen podcast listening platform!